首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

2107869

無導管胰島素幫浦市場：按組件、通路和地區分類

Tubeless Insulin Pump Market, By Component, By Distribution Channel, By Geography

出版日期: 2026年07月28日 | 出版商:

Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，無導管胰島素幫浦市場規模將達到 31.7 億美元，到 2033 年將達到 114.1 億美元。預計 2026 年至 2033 年的複合年成長率將達到 20.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	31.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	20.10%	2033年市場規模預測：	114.1億美元

隨著自動化胰島素輸注系統的應用日益普及，對糖尿病管理工具的需求不斷成長，以及人們對持續血糖控制解決方案的關注度不斷提高，市場正在經歷一場變革。無導管胰島素泵，包括貼片式、穿戴式式和智慧型手機控制式等型號，能夠幫助患者高效地注射胰島素，同時滿足精準、便捷和安全的標準。市場涵蓋了第1型糖尿病、胰島素依賴型第2型糖尿病、兒童糖尿病、成人糖尿病、妊娠糖尿病、住院治療和居家管理等多種應用領域。

患者和醫護人員正致力於提高胰島素輸注的精準性和操作便利性，以改善血糖控制、確保治療順從性並維持生活品質。持續血糖監測整合、劑量演算法和小型胰島素幫浦晶片技術的進步正在提升胰島素幫浦的性能，尤其對於需要頻繁調整胰島素劑量或接受重症監護的患者更是如此。此外，行動應用程式和互聯糖尿病平台的日益普及有助於最佳化劑量計算和血糖監測，從而改善臨床療效並減輕糖尿病管理的負擔。

市場動態

由於糖尿病盛行率不斷上升、自動化胰島素輸注系統應用日益廣泛，以及對能夠有效控制血糖的設備需求不斷成長，市場呈現出強勁的成長動能。市場成長的主要驅動力來自醫療設備製造商和糖尿病護理機構，他們尋求的是緊湊、可程式設計且易於使用的胰島素輸注平台，尤其適用於兒童、青少年、成人、胰島素依賴型2型糖尿病患者、孕婦以及需要強化胰島素治療的患者。一次性胰島素幫浦組件、輸注導管、無線控制器、行動應用程式和血糖感測技術在胰島素幫浦的運作中發揮核心作用，有助於實現基礎胰島素輸注的自動化、簡化大劑量投藥並降低注射頻率。由於人們越來越重視治療的柔軟性、設備的舒適性和居家糖尿病護理，對無導管胰島素幫浦的需求也不斷成長。

閉合迴路胰島素輸注系統的普及正在推動市場成長。這主要得益於與持續血糖監測設備整合技術的進步、先進劑量演算法的出現以及可與智慧型手機配合使用的胰島素幫浦（旨在匹配個別血糖模式）。包括預測性警報、遠端監測、自動追加Bolus校正和即時數據共用在內的互聯方法，有助於提高血糖達標時間並降低嚴重低血糖的風險。

此外，對便利性、微創糖尿病管理方式日益成長的需求也推動了市場擴張。內分泌科醫生、糖尿病專家、糖尿病教育者、醫療設備製造商、藥房和專科治療中心在推廣和支持胰島素幫浦的使用方面發揮著至關重要的作用。隨著人們對數位化糖尿病管理的認知度不斷提高，預計市場將受益於保險覆蓋範圍的擴大、醫療設備獲取途徑的改善以及更緊湊、互通性且價格更實惠的新一代胰島素輸註解決方案的推出。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析了無管胰島素幫浦市場主要參與者的概況：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份「無管胰島素幫浦市場」報告針對產業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用無管胰島素幫浦市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Medtronic Plc.
- Medtrum Technologies, Inc.
- Tandem Diabetes Care
- Insulet Corporation
- Animas Corporation
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1298

Tubeless Insulin Pump Market is estimated to be valued at USD 3.17 Bn in 2026 and is expected to reach USD 11.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 20.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.17 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	20.10%	2033 Value Projection:	USD 11.41 Bn

The market is undergoing a transformation owing to the rising adoption of automated insulin delivery systems, increasing demand for diabetes management options, and growing emphasis on continuous glucose control solutions. Tubeless insulin pumps like patch-based, wearable, and smartphone-controlled systems, allows the patients to administer insulin efficiently while also addressing dosing accuracy, convenience, and safety standards. The market includes product applications like type 1 diabetes, insulin-dependent type 2 diabetes, pediatric diabetes, adult diabetes, gestational diabetes, hospital care, and home-based management.

Patients and healthcare providers are focusing on precise insulin delivery and user-friendly approaches to enhance glycemic outcomes, ensure treatment adherence, and maintain quality of life. The developments in the continuous glucose monitoring integration, dosing algorithms, and compact pod technologies are improving pump performance, especially in patients requiring frequent insulin adjustments or intensive therapy. In addition, the growing use of mobile applications and connected diabetes platforms helps optimize dose calculation and glucose monitoring, thereby improving clinical outcomes and reducing burden of diabetes management.

Market Dynamics

The market is witnessing major momentum owing to the increasing prevalence of diabetes, rising adoption of automated insulin delivery systems, and the growing need for devices capable of supporting effective glycemic management. The market's growth is largely driven by medical device companies and diabetes care providers seeking compact, programmable, and user-friendly insulin delivery platforms, especially for children, adolescents, adults, insulin-dependent type 2 diabetes patients, pregnant women, and individuals requiring intensive insulin therapy. Disposable pods, infusion cannulas, wireless controllers, mobile applications, and glucose-sensing technologies play a central role in pump operation, thereby helping automate basal insulin delivery, simplify bolus administration, and reduce injection frequency. The rising focus on treatment flexibility, device wearability, and home-based diabetes care is strengthening the demand for tubeless insulin pumps.

The expansion of closed-loop insulin delivery systems is fueling market growth. This is mainly driven by increasing integration with continuous glucose monitoring devices, availability of advanced dosing algorithms, and smartphone-enabled pumps designed according to individual glucose patterns. Connected approaches involving predictive alerts, remote monitoring, automated correction boluses, and real-time data sharing help improve time-in-range and reduce the risk of severe hypoglycemia.

The rising demand for convenient and minimally invasive diabetes management is also propelling the market. Endocrinologists, diabetologists, diabetes educators, device manufacturers, pharmacies, and specialized treatment centers play a crucial role in recommending and supporting wider pump adoption. As awareness of digital diabetes management grows, the market is expected to benefit from reimbursement expansion, improved device accessibility, and the introduction of more compact, interoperable, affordable, and next-generation insulin delivery solutions.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Tubeless Insulin Pump Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic Plc., Medtrum Technologies, Inc., Tandem Diabetes Care, Insulet Corporation, and Animas Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Tubeless Insulin Pump Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Tubeless Insulin Pump Market

Market Segmentation

By Component (Revenue, USD Bn, 2021-2033)
Pod/Patch
Remote
Accessories (reservoirs, batteries, etc.)
By Distribution Channel (Revenue, USD Bn, 2021-2033)
Hospitals
Pharmacies
E-commerce
Global Tubeless Insulin Pump Market, By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players Insights
Medtronic Plc.
Medtrum Technologies, Inc.
Tandem Diabetes Care
Insulet Corporation
Animas Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Disease Type Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Tubeless Insulin Pump Market, By Component, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Pod/Patch
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Remote
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Accessories (reservoirs, batteries, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Tubeless Insulin Pump Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
E-commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Tubeless Insulin Pump Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Medtronic Plc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Medtrum Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Tandem Diabetes Care
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Insulet Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Animas Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views